PMC:7376974 / 37796-38039 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T159","span":{"begin":65,"end":72},"obj":"Body_part"}],"attributes":[{"id":"A159","pred":"fma_id","subj":"T159","obj":"http://purl.org/sig/ont/fma/fma82801"}],"text":"hylene oxide units), while a nanomolar IC50 was achieved with 36 mannose fullerenes with a longer spacer (PEG, with 3 ethylene oxide units) (Table 3). This first proof-of-concept study was then expanded, aiming to obtain a better antiviral act"}

{"project":"LitCovid-PubTator","denotations":[{"id":"585","span":{"begin":65,"end":83},"obj":"Chemical"},{"id":"586","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"587","span":{"begin":118,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A586","pred":"tao:has_database_id","subj":"586","obj":"MESH:D011092"},{"id":"A587","pred":"tao:has_database_id","subj":"587","obj":"MESH:D005027"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hylene oxide units), while a nanomolar IC50 was achieved with 36 mannose fullerenes with a longer spacer (PEG, with 3 ethylene oxide units) (Table 3). This first proof-of-concept study was then expanded, aiming to obtain a better antiviral act"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T352","span":{"begin":27,"end":28},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T353","span":{"begin":62,"end":64},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T354","span":{"begin":89,"end":90},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T355","span":{"begin":221,"end":222},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"hylene oxide units), while a nanomolar IC50 was achieved with 36 mannose fullerenes with a longer spacer (PEG, with 3 ethylene oxide units) (Table 3). This first proof-of-concept study was then expanded, aiming to obtain a better antiviral act"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T464","span":{"begin":7,"end":12},"obj":"Chemical"},{"id":"T466","span":{"begin":65,"end":72},"obj":"Chemical"},{"id":"T467","span":{"begin":73,"end":83},"obj":"Chemical"},{"id":"T468","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"T469","span":{"begin":118,"end":126},"obj":"Chemical"},{"id":"T470","span":{"begin":127,"end":132},"obj":"Chemical"},{"id":"T472","span":{"begin":230,"end":239},"obj":"Chemical"}],"attributes":[{"id":"A464","pred":"chebi_id","subj":"T464","obj":"http://purl.obolibrary.org/obo/CHEBI_25741"},{"id":"A465","pred":"chebi_id","subj":"T464","obj":"http://purl.obolibrary.org/obo/CHEBI_29356"},{"id":"A466","pred":"chebi_id","subj":"T466","obj":"http://purl.obolibrary.org/obo/CHEBI_37684"},{"id":"A467","pred":"chebi_id","subj":"T467","obj":"http://purl.obolibrary.org/obo/CHEBI_33416"},{"id":"A468","pred":"chebi_id","subj":"T468","obj":"http://purl.obolibrary.org/obo/CHEBI_46793"},{"id":"A469","pred":"chebi_id","subj":"T469","obj":"http://purl.obolibrary.org/obo/CHEBI_29362"},{"id":"A470","pred":"chebi_id","subj":"T470","obj":"http://purl.obolibrary.org/obo/CHEBI_25741"},{"id":"A471","pred":"chebi_id","subj":"T470","obj":"http://purl.obolibrary.org/obo/CHEBI_29356"},{"id":"A472","pred":"chebi_id","subj":"T472","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"hylene oxide units), while a nanomolar IC50 was achieved with 36 mannose fullerenes with a longer spacer (PEG, with 3 ethylene oxide units) (Table 3). This first proof-of-concept study was then expanded, aiming to obtain a better antiviral act"}